« Return to News | Study Conduct

Medical Research Network expands with US office

Tuesday, October 25, 2011 01:21 PM

Medical Research Network (MRN) has opened a US office in Raleigh, North Carolina to better service clients in North America while at its UK headquarters in Milton Keynes, the company has completed a management restructure to allow the leadership team more time to focus on its continued expansion.

Since its inception five years ago, MRN has experienced sustained growth and the opening of the new North American office marks a significant step in expansion of the company’s global offering. Already servicing more than 45 countries worldwide, the new office will allow quicker and more targeted nursing provision to be provided across North America.

The UK restructure has seen the current directors promoted to vice presidents and an expanded team of directors put in place to provide a structured program of expansion and business generation.

MRN provides home trial support, site nurse support and bespoke flexible solutions for clinical trial patient recruitment and retention across the globe. It works with many of the largest pharmaceutical, CRO and biotechnology organizations as well as with a large number of specialist and niche companies with complex and specialized therapies under research.

Share:          
CWWeekly

May 14

Survey: Confusing rules governing pediatric trials add to bigger challenge of finding enough participants

Researchers: Current ethics don't cover phase IV, as trials produce biased marketing detached from science

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

May

Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…

Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…

Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2012 CenterWatch.